Literature DB >> 20592236

Role of c-Cbl-dependent regulation of phospholipase Cgamma1 activation in experimental choroidal neovascularization.

Deeba Husain1, Rosana D Meyer, Manisha Mehta, Walther M Pfeifer, Eva Chou, Gregory Navruzbekov, Ednan Ahmed, Nader Rahimi.   

Abstract

PURPOSE: Activation of phospholipase Cγ1 (PLCγ1) by vascular endothelial growth factor receptor (VEGFR)-2 is necessary for proliferation and tube formation of endothelial cells in vitro. Previous work has demonstrated that Casitas B-lineage lymphoma (c-Cbl) promotes ubiquitination of PLCγ1 and suppression of its tyrosine phosphorylation. This study was designed to evaluate the importance of PLCγ1 and c-Cbl in experimental choroidal neovascularization (CNV).
METHODS: The role of PLCγ1 was studied in three models of angiogenesis: the endothelial cell culture system, the chorioallantoic membrane (CAM) assay, and the laser-induced CNV model. Endothelial cells were analyzed for the role of PLCγ1 in promoting tube formation. CAMs were incubated with pharmacologic agents that either inhibit or stimulate PLCγ1. CNV was induced in wild-type and c-Cbl-knockout mice, and the progression of CNV was evaluated by fluorescein angiography.
RESULTS: Activation of PLCγ1 was necessary for tube formation of endothelial cells. PLCγ1 stimulation increased the growth of blood vessels and conversely, PLCγ1 inhibition decreased the growth of blood vessels in the CAM model. CNV lesions in the c-Cbl-knockout mice were significantly greater in number, more confluent, and increased in size with time, compared with those in the control wild-type mice.
CONCLUSIONS: The data show that PLCγ1 plays an important role in angiogenesis. Loss of c-Cbl results in enhanced CNV in the eye. The study also shows that c-Cbl plays an important role in ocular angiogenesis, suggesting that modulation of c-Cbl activity or inhibition of PLCγ1 would be a compelling target for antiangiogenesis therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592236      PMCID: PMC3055779          DOI: 10.1167/iovs.10-5255

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

Review 1.  Angiogenesis in health and disease.

Authors:  Peter Carmeliet
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 2.  Choroidal neovascularization.

Authors:  Hans E Grossniklaus; W Richard Green
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

3.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice.

Authors:  M Naramura; H K Kole; R J Hu; H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation.

Authors:  Mayumi Naramura; Ihn-Kyung Jang; Hemanta Kole; Fang Huang; Diana Haines; Hua Gu
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

5.  Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice.

Authors:  Yoshiko Sakurai; Kaori Ohgimoto; Yuki Kataoka; Nobuaki Yoshida; Masabumi Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-11       Impact factor: 11.205

6.  Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor.

Authors:  Yan Li; Yi-Chang Jia; Kai Cui; Ning Li; Zai-Yu Zheng; Yi-Zheng Wang; Xiao-Bing Yuan
Journal:  Nature       Date:  2005-03-09       Impact factor: 49.962

7.  phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development.

Authors:  Nathan D Lawson; Joshua W Mugford; Brigid A Diamond; Brant M Weinstein
Journal:  Genes Dev       Date:  2003-06-01       Impact factor: 11.361

Review 8.  VEGF and the quest for tumour angiogenesis factors.

Authors:  Napoleone Ferrara
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

9.  A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor.

Authors:  T Eichholtz; D B de Bont; J de Widt; R M Liskamp; H L Ploegh
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

10.  Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice.

Authors:  M A Murphy; R G Schnall; D J Venter; L Barnett; I Bertoncello; C B Thien; W Y Langdon; D D Bowtell
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

View more
  13 in total

1.  The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway.

Authors:  Sowmya Shivanna; Itrat Harrold; Moshe Shashar; Rosanna Meyer; Chrystelle Kiang; Jean Francis; Qing Zhao; Hui Feng; Elazer R Edelman; Nader Rahimi; Vipul C Chitalia
Journal:  J Biol Chem       Date:  2015-03-17       Impact factor: 5.157

2.  Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization.

Authors:  Ramin Nourinia; Mozhgan Rezaei Kanavi; Amir Kaharkaboudi; Seyed Iman Taghavi; Seyed Javid Aldavood; Soesiawati R Darjatmoko; Shoujian Wang; Zafer Gurel; Jeremy A Lavine; Sare Safi; Hamid Ahmadieh; Narsis Daftarian; Nader Sheibani
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

3.  Identification of PDCL3 as a novel chaperone protein involved in the generation of functional VEGF receptor 2.

Authors:  Srimathi Srinivasan; Rosana D Meyer; Ricardo Lugo; Nader Rahimi
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

4.  c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulation.

Authors:  Vipul Chitalia; Sowmya Shivanna; Jordi Martorell; Rosana Meyer; Elazer Edelman; Nader Rahimi
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

5.  PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation.

Authors:  Rosana D Meyer; Srimathi Srinivasan; Amrik J Singh; John E Mahoney; Kobra Rezazadeh Gharahassanlou; Nader Rahimi
Journal:  Mol Cell Biol       Date:  2011-03-14       Impact factor: 4.272

6.  Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts.

Authors:  Evita M Lindholm; Alexandr Kristian; Hawa Nalwoga; Kristi Krüger; Ståle Nygård; Lars A Akslen; Gunhild M Mælandsmo; Olav Engebraaten
Journal:  Mol Oncol       Date:  2012-03-31       Impact factor: 6.603

Review 7.  The ubiquitin-proteasome system meets angiogenesis.

Authors:  Nader Rahimi
Journal:  Mol Cancer Ther       Date:  2012-02-21       Impact factor: 6.261

8.  Haploinsufficiency of Casitas B-Lineage Lymphoma Augments the Progression of Colon Cancer in the Background of Adenomatous Polyposis Coli Inactivation.

Authors:  Sean Richards; Joshua Walker; Masako Nakanishi; Mostafa Belghasem; Chimera Lyle; Nkiruka Arinze; Marc A Napoleon; Jonathan D Ravid; Nicholas Crossland; Qing Zhao; Daniel Rosenberg; Nader Rahimi; Vipul C Chitalia
Journal:  Am J Pathol       Date:  2020-02-26       Impact factor: 4.307

9.  Molecular mechanisms of (R,R)ZX-5 on NO synthesis and its anti-angiogenic effect.

Authors:  Li Pan; Jia-Liang Hu; Wen-Jing Wang; Xiao-Juan Zhang; Jin Wei; Zhen-Dong Liu; Yi-Hua Zhang; Han-Mei Xu
Journal:  Int J Mol Sci       Date:  2012-02-29       Impact factor: 6.208

Review 10.  Mechanisms and regulation of endothelial VEGF receptor signalling.

Authors:  Michael Simons; Emma Gordon; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2016-07-27       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.